Uploaded June 2026 | Updated September 2026, 2 weeks ago

---

GLP-1 Drugs are evolving from needle injections to pills. They're also getting cheaper. And backed by government and insurance. Which means 42% of the the public that is obese and a significant share of the overweight but not obese populace will be eligible for a cheap and easy pill to curtail their appetite. What happens when caloric demand drops by 10 or 20% nationwide?

Damian Mason speaks about issues impacting the Business of Agriculture.

The Business of Agriculture Podcast with Damian Mason is brought to you by:
- Ag View Solutions | agviewsolutions.com
- Tidal Grow Agriscience | tidalgrowag.com
- Nano-Yield | nano-yield.com
- Life Scientific | lifescientific.com/en/north-america

#farming #podcast #agribusiness #agriculture #farmlife #damianmason

Listen to more great content here 👉 youtube.com/playlist?list=PLOTg4XaRuYh3dLeMyCz0vfu936zhVUQaX&si=MhMMdG-KJ5Lz3mkl

Check out my work with XtremeAg:
- Cutting The Curve Podcast | https://www.xtremeag.farm/podcasts
- The Granary | https://www.xtremeag.farm/the-granary

Keep up with me on social media!
damianmason.com
facebook.com/DamianPMason
instagram.com/DamianPMason
twitter.com/DamianPMason
linkedin.com/in/damianmason